These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32398584)

  • 1. Reticular Corneal Edema or Corneal Honeycombing in Eyes Treated With Netarsudil: A Case Series.
    Moumneh K; Sheybani A; Fellman RL; Godfrey DG; Grover DS
    J Glaucoma; 2020 Jul; 29(7):607-610. PubMed ID: 32398584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netarsudil-Associated Reticular Corneal Epithelial Edema with Raised Intraocular Pressure.
    Liu KC; Gupta D
    Ophthalmol Glaucoma; 2019; 2(3):166. PubMed ID: 32672585
    [No Abstract]   [Full Text] [Related]  

  • 3. Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil.
    Chen H; McMillin JC; Frankfort BJ; Al-Mohtaseb Z
    J Glaucoma; 2020 Nov; 29(11):e124-e126. PubMed ID: 32826765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2).
    Kahook MY; Serle JB; Mah FS; Kim T; Raizman MB; Heah T; Ramirez-Davis N; Kopczynski CC; Usner DW; Novack GD;
    Am J Ophthalmol; 2019 Apr; 200():130-137. PubMed ID: 30653957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Patient With Glaucoma With Corneal Edema.
    Chen TC; Jurkunas U; Chodosh J
    JAMA Ophthalmol; 2020 Aug; 138(8):917-918. PubMed ID: 32584374
    [No Abstract]   [Full Text] [Related]  

  • 6. Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial.
    Asrani S; Robin AL; Serle JB; Lewis RA; Usner DW; Kopczynski CC; Heah T;
    Am J Ophthalmol; 2019 Nov; 207():248-257. PubMed ID: 31229466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2.
    Wisely CE; Sheng H; Heah T; Kim T
    Adv Ther; 2020 Mar; 37(3):1114-1123. PubMed ID: 31981106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible Corneal Endothelial Abnormalities With Netarsudil.
    Tanna AP; Esfandiari H; Teramoto K
    J Glaucoma; 2020 Jun; 29(6):e41-e43. PubMed ID: 32224803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honeycomb Epithelial Edema Associated With Rho Kinase Inhibition: A Case Series and Review of the Literature.
    Lyons LJ; Wu KY; Baratz KH; Sit AJ
    Cornea; 2022 Feb; 41(2):243-248. PubMed ID: 35037906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension.
    Kopczynski CC; Heah T
    Drugs Today (Barc); 2018 Aug; 54(8):467-478. PubMed ID: 30209441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
    Serle JB; Katz LJ; McLaurin E; Heah T; Ramirez-Davis N; Usner DW; Novack GD; Kopczynski CC;
    Am J Ophthalmol; 2018 Feb; 186():116-127. PubMed ID: 29199013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Netarsudil Ophthalmic Solution 0.02%: First Global Approval.
    Hoy SM
    Drugs; 2018 Mar; 78(3):389-396. PubMed ID: 29453668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series.
    Wisely CE; Liu KC; Gupta D; Carlson AN; Asrani SG; Kim T
    Am J Ophthalmol; 2020 Sep; 217():20-26. PubMed ID: 32289295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study.
    Khouri AS; Serle JB; Bacharach J; Usner DW; Lewis RA; Braswell P; Kopczynski CC; Heah T;
    Am J Ophthalmol; 2019 Aug; 204():97-104. PubMed ID: 30862500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil.
    Jeang LJ; Shah AS; Hammer JD; Tuli SS
    Digit J Ophthalmol; 2022; 28(8):34-37. PubMed ID: 35854963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension.
    Aref AA; Geyman LS; Zakieh AR; Alotaibi HM
    Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1073-1079. PubMed ID: 31842637
    [No Abstract]   [Full Text] [Related]  

  • 17. Transient Reticular Cystic Corneal Epithelial Edema With Topical Netarsudil: A Case Series and Review.
    LoBue SA; Moustafa GA; Vu A; Amin M; Nguyen T; Goyal H
    Cornea; 2021 Aug; 40(8):1048-1054. PubMed ID: 33369939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reticular Epithelial Edema in Edematous Corneas Treated with Netarsudil.
    Fernandez MM
    Ophthalmology; 2018 Nov; 125(11):1709. PubMed ID: 30318038
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension.
    Araie M; Sugiyama K; Aso K; Kanemoto K; Kothapalli K; Kopczynski C; Senchyna M; Hollander DA
    Adv Ther; 2021 Apr; 38(4):1757-1775. PubMed ID: 33629227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Netarsudil-related Eyelid Wound Dehiscence.
    Kim HM; Tran AQ; Yang C; Dagi Glass LR
    J Glaucoma; 2021 Feb; 30(2):206-208. PubMed ID: 33861552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.